CovalX Instruments Inc, based in Saugus, MA, is a leading provider of innovative solutions for characterizing therapeutic proteins in the life science industry. With over a decade of experience and a global client base, the company offers services such as epitope mapping, XL-MS, HDX-MS, de novo sequencing, drug discovery, and mAb characterization.
With a strong focus on patents and publications, CovalX showcases its expertise in the field and is dedicated to serving scientists in making breakthrough discoveries that benefit humanity. The company has strategic locations in Switzerland, the United States, and France, further enhancing its global reach and impact in the scientific community.